T Scientific Co.Ltd (KQ:057680) — Stock Price
T Scientific Co.Ltd (KQ:057680) is currently trading at ₩1650.00 KRW, down 0.30% today. Over the past 52 weeks, shares have ranged between ₩576.00 and ₩2960.00. This page tracks T Scientific Co.Ltd's live share price on the KQ exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see T Scientific Co.Ltd (057680) total market value.
T Scientific Co.Ltd (057680) Stock Price Chart — Daily History & Trading Volume
The chart below tracks T Scientific Co.Ltd's daily closing share price and trading volume on the KQ exchange over the past year, giving a clear view of recent price momentum and liquidity.
T Scientific Co.Ltd Income Statement — Revenue, Profit & Earnings by Year
T Scientific Co.Ltd's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Revenue | ₩43.02 Billion | ₩26.77 Billion | ₩8.69 Billion | ₩10.08 Billion | ₩9.52 Billion |
| Cost of Revenue | ₩33.06 Billion | ₩18.65 Billion | ₩4.51 Billion | ₩5.83 Billion | ₩5.77 Billion |
| Gross Profit | ₩9.95 Billion | ₩8.12 Billion | ₩4.19 Billion | ₩4.25 Billion | ₩3.75 Billion |
| Research & Development | ₩1.27 Billion | ₩902.90 Million | ₩273.43 Million | ₩296.59 Million | ₩350.01 Million |
| SG&A | ₩17.50 Billion | ₩11.73 Billion | ₩5.98 Billion | ₩2.69 Billion | ₩2.39 Billion |
| Total Operating Expenses | ₩50.87 Billion | ₩32.39 Billion | ₩11.18 Billion | ₩9.08 Billion | ₩8.79 Billion |
| Operating Income | ₩-8.97 Billion | ₩-32.36 Billion | ₩-2.49 Billion | ₩1.00 Billion | ₩725.16 Million |
| EBITDA | — | — | — | — | — |
| EBIT | — | — | — | — | — |
| Interest Expense | ₩866.07 Million | ₩2.71 Billion | ₩2.94 Billion | ₩1.28 Billion | ₩514.83 Million |
| Income Before Tax | ₩1.31 Billion | ₩-54.26 Billion | ₩-15.89 Billion | ₩-2.96 Billion | ₩-683.50 Million |
| Income Tax Expense | — | — | — | — | — |
| Net Income | ₩2.22 Billion | ₩-45.41 Billion | ₩-11.11 Billion | ₩-3.16 Billion | ₩652.38 Million |
T Scientific Co.Ltd Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes T Scientific Co.Ltd's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Assets | ₩163.27 Billion | ₩173.98 Billion | ₩262.54 Billion | ₩296.29 Billion | ₩108.72 Billion |
| Total Current Assets | ₩22.56 Billion | ₩31.04 Billion | ₩45.73 Billion | ₩30.90 Billion | ₩28.84 Billion |
| Cash & Equivalents | ₩3.08 Billion | ₩8.48 Billion | ₩11.10 Billion | ₩4.25 Billion | ₩5.58 Billion |
| Short-term Investments | ₩3.88 Billion | ₩5.46 Billion | ₩19.00 Billion | ₩11.00 Billion | ₩9.00 Billion |
| Net Receivables | ₩-3.78 Billion | ₩13.59 Billion | ₩4.78 Billion | ₩7.35 Billion | ₩8.94 Billion |
| Inventory | ₩-262.22 Million | ₩198.40 Million | ₩30.55 Million | — | ₩0.00 |
| Property, Plant & Equipment | ₩2.18 Billion | ₩1.51 Billion | ₩2.34 Billion | ₩517.99 Million | ₩619.71 Million |
| Goodwill | ₩4.15 Billion | ₩1.35 Billion | ₩26.82 Billion | ₩0.00 | ₩0.00 |
| Total Liabilities | ₩22.95 Billion | ₩43.43 Billion | ₩84.57 Billion | ₩74.39 Billion | ₩25.01 Billion |
| Total Current Liabilities | ₩22.73 Billion | ₩40.73 Billion | ₩45.02 Billion | ₩32.14 Billion | ₩15.78 Billion |
| Long-term Debt | — | ₩0.00 | ₩10.50 Billion | ₩0.00 | ₩4.51 Billion |
| Net Debt | ₩2.40 Billion | ₩4.21 Billion | ₩25.97 Billion | ₩12.50 Billion | — |
| Total Stockholder Equity | ₩140.32 Billion | ₩131.23 Billion | ₩177.97 Billion | ₩221.89 Billion | ₩83.70 Billion |
| Retained Earnings | ₩-71.95 Billion | ₩-73.46 Billion | ₩-27.87 Billion | ₩-16.69 Billion | ₩-13.53 Billion |
T Scientific Co.Ltd Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how T Scientific Co.Ltd generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | ₩-13.16 Billion | ₩-11.15 Billion | ₩-2.26 Billion | ₩-42.06 Million | ₩-2.10 Billion |
| Capital Expenditures | ₩116.07 Million | ₩281.29 Million | ₩435.80 Million | ₩93.91 Million | ₩85.52 Million |
| Free Cash Flow | ₩-13.28 Billion | ₩-11.43 Billion | ₩-2.69 Billion | ₩-135.97 Million | ₩-2.18 Billion |
| Investing Cash Flow | ₩16.25 Billion | ₩10.46 Billion | ₩-41.60 Billion | ₩-16.70 Billion | ₩-1.59 Billion |
| Financing Cash Flow | ₩-8.49 Billion | ₩-1.92 Billion | ₩50.70 Billion | ₩15.41 Billion | ₩5.32 Billion |
| Dividends Paid | — | — | — | — | — |
| Stock-Based Compensation | — | — | — | — | — |
| Depreciation | ₩1.20 Billion | ₩1.17 Billion | ₩300.40 Million | ₩172.75 Million | ₩193.68 Million |
| Change in Cash | ₩-5.40 Billion | ₩-2.62 Billion | ₩6.85 Billion | ₩-1.33 Billion | ₩1.63 Billion |
T Scientific Co.Ltd Earnings History — EPS Actual vs. Analyst Estimates
Track T Scientific Co.Ltd's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Sep 30, 2025 | 2.16 | — | — |
| Jun 30, 2025 | 22.94 | — | — |
| Mar 31, 2025 | -48.74 | — | — |
| Dec 31, 2024 | 17.19 | — | — |
| Sep 30, 2024 | -60.26 | — | — |
| Jun 30, 2024 | -86.06 | — | — |
| Mar 31, 2024 | 150.02 | — | — |
| Feb 15, 2024 | -497.65 | — | — |